Genital herpes and human immunodeficiency virus: double trouble
about
An estimate of the global prevalence and incidence of herpes simplex virus type 2 infectionInfectious co-factors in HIV-1 transmission herpes simplex virus type-2 and HIV-1: new insights and interventionsHerpes simplex epithelial and stromal keratitis: an epidemiologic updateEpisodic therapy for genital herpes in sub-saharan Africa: a pooled analysis from three randomized controlled trials.Regional differences in prevalence of HIV-1 discordance in Africa and enrollment of HIV-1 discordant couples into an HIV-1 prevention trial.Genital herpes has played a more important role than any other sexually transmitted infection in driving HIV prevalence in Africa.Relatively low HIV infection rates in rural Uganda, but with high potential for a rise: a cohort study in Kayunga District, UgandaSeroprevalence and factors associated with herpes simplex virus type 2 among HIV-negative high-risk men who have sex with men from Rio de Janeiro, Brazil: a cross-sectional studyPPARgamma and LXR signaling inhibit dendritic cell-mediated HIV-1 capture and trans-infectionAntibody to HSV gD peptide induced by vaccination does not protect against HSV-2 infection in HSV-2 seronegative womenPopulation level impact of an imperfect prophylactic vaccine for herpes simplex virus-2Susceptibility to genital herpes as a biomarker predictive of increased HIV risk: expansion of a murine model of microbicide safetyEffect of variable transmission rate on the dynamics of HIV in sub-Saharan Africa.Long-term virological, immunological and mortality outcomes in a cohort of HIV-infected female sex workers treated with highly active antiretroviral therapy in Africa.Long-term impact of acyclovir suppressive therapy on genital and plasma HIV RNA in Tanzanian women: a randomized controlled trial.Deciphering the epidemic synergy of herpes simplex virus type 2 (HSV-2) on human immunodeficiency virus type 1 (HIV-1) infection among women in sub-Saharan Africa.HIV-1 transmission within marriage in rural Uganda: a longitudinal studyRecombinant vesicular stomatitis virus vectors expressing herpes simplex virus type 2 gD elicit robust CD4+ Th1 immune responses and are protective in mouse and guinea pig models of vaginal challenge.Sensitivity and specificity of herpes simplex virus-2 serological assays among HIV-infected and uninfected urban UgandansMale circumcision significantly reduces prevalence and load of genital anaerobic bacteria.Direct application of plasmid DNA containing type I interferon transgenes to vaginal mucosa inhibits HSV-2 mediated mortality.Interactions of HIV, other sexually transmitted diseases, and genital tract inflammation facilitating local pathogen transmission and acquisition.Circumcision and reduced risk of self-reported penile coital injuries: results from a randomized controlled trial in Kisumu, Kenya.Getting research into policy - Herpes simplex virus type-2 (HSV-2) treatment and HIV infection: international guidelines formulation and the case of Ghana.Using geospatial modelling to optimize the rollout of antiretroviral-based pre-exposure HIV interventions in Sub-Saharan AfricaPrevalence, incidence and determinants of herpes simplex virus type 2 infection among HIV-seronegative women at high-risk of HIV infection: a prospective study in Beira, Mozambique.Systemic and mucosal differences in HIV burden, immune, and therapeutic responsesGenital Ulcer Disease: How Worrisome Is It Today? A Status Report from New Delhi, IndiaEcological analysis of the association between high-risk population parameters and HIV prevalence among pregnant women enrolled in sentinel surveillance in four Southern India statesOptimizing siRNA delivery to the genital mucosasiRNA-based topical microbicides targeting sexually transmitted infections.Genital herpes and its management.A genital tract peptide epitope vaccine targeting TLR-2 efficiently induces local and systemic CD8+ T cells and protects against herpes simplex virus type 2 challengeHSV-2 Seroepidemiology and Risk Factors among Iranian Women: A Time to New Thinking.Genital herpes in Canada: Deciphering the hidden epidemicPrevalence of Herpes Simplex Virus 2 (HSV-2) infection and associated risk factors in a cohort of HIV negative women in Durban, South Africa.Impact of herpes simplex virus type 2 on HIV-1 acquisition and progression in an HIV vaccine trial (the Step study)Current trends in negative immuno-synergy between two sexually transmitted infectious viruses: HIV-1 and HSV-1/2.Rapid tests for sexually transmitted infections (STIs): the way forwardSynthetic α-Hydroxytropolones Inhibit Replication of Wild-Type and Acyclovir-Resistant Herpes Simplex Viruses.
P2860
Q24646809-5E5B346B-6F27-43DB-8B90-7BDE7DDD9B55Q26823594-925666C9-FF92-4D5C-9071-18132297D7DBQ26853504-1CC75BAC-514C-4410-B06E-E36124213352Q31028568-420D8EF1-160D-442B-9CF6-008B5E2F6304Q33313869-7F26F6F4-6935-4D6C-B43D-DF304F69E77AQ33336603-8ED8E9B3-F4CD-42D9-8DD6-62B55BF96B3AQ33398034-939E9030-C926-48AA-BBBD-96EB233AC6A1Q33425027-9E927B7B-935E-42C2-996A-C1F04B1AD341Q33628817-2CE867DE-B1AB-4593-9B0E-C30F3B3EDA60Q33663463-CCBC4398-24EC-4E44-ABE2-5E5FC01A6F99Q33812029-540CEF88-4DB0-4707-A635-D2F36C990934Q33889911-8EFC818B-2F76-4912-8FD3-3F78E93D0A60Q33990906-4D699FBD-E9FF-4F7F-B076-C48EC58058C0Q34019508-FBBBA11F-648D-4CFB-A371-5035D81642CDQ34168234-4BD1CE86-2DA7-4670-8966-1B5AEC5003E6Q34386832-B5743C52-015C-4E12-97C3-31DF1FA56054Q34579991-AA084EC0-F463-4D0B-9609-4491F4515644Q34647625-729E73E5-F9D6-47F6-B044-A843D78387D3Q34670442-143F2C8D-F4F3-4C1C-A0D1-720A65334503Q34671556-9650B722-E782-4B4A-8B79-172312A34BFAQ34718486-D73E7B8C-1965-4E76-8BC7-638152A2E78BQ34799419-FFB0287F-42E1-403C-8CCB-96B56F8BDD0CQ34960331-B57FC4E4-2C22-4067-800F-F1891ACE8380Q35062477-6F98DE49-F562-40F6-B015-5976DE9A7EFEQ35067756-9B2F3C54-CCEB-4F94-BC2A-4338767625A6Q35107935-938458B0-6325-4225-B4FB-175188027FD7Q35190200-D40B9662-676E-41DE-845D-C49AD39CAA83Q35623718-80C02633-0777-4236-836E-288315802869Q35656701-F83B1357-B414-463C-BABB-B7EAABDEB9CFQ35766249-D291382F-6B6B-4AE3-AC3C-E17443BF7DE5Q35766254-115B9DB6-B983-444B-8A49-AD002F290DDEQ35800206-4EAB8CEC-E5CF-4A3F-93D3-0BC18A60F2ABQ35871689-76DE5D04-3584-4CED-AB71-7FD42ADDA876Q36022239-E5BCFEC9-AE37-4376-9638-422306ADABA4Q36029499-DF2793DE-C80E-4C7E-8B56-A5747DAE78B2Q36220941-B61841BE-62C7-4E5F-88D8-086F1CBD3ABCQ36247111-3A8167E7-588C-4973-A78A-F21B41EE91A1Q36555158-92C92127-2E9A-40D8-94CE-71A05E2CBDBFQ36675814-9982CF3E-F6D1-4220-AB1C-C4EF7E5BC04BQ36730096-443903C3-9BD5-4558-AD4F-A81D940F7C82
P2860
Genital herpes and human immunodeficiency virus: double trouble
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Genital herpes and human immunodeficiency virus: double trouble
@ast
Genital herpes and human immunodeficiency virus: double trouble
@en
type
label
Genital herpes and human immunodeficiency virus: double trouble
@ast
Genital herpes and human immunodeficiency virus: double trouble
@en
prefLabel
Genital herpes and human immunodeficiency virus: double trouble
@ast
Genital herpes and human immunodeficiency virus: double trouble
@en
P2093
P1476
Genital herpes and human immunodeficiency virus: double trouble
@en
P2093
Connie Celum
Marcia Weaver
Ruth Levine
P304
P407
P577
2004-06-01T00:00:00Z